
Arcinova - A Quotient Sciences Company
Arcinova는 초기 발견에서 개념 증명 및 그 이후까지 신약 개발을 가속화합니다.
Batch Size: Small
Category / Product: FDF / DRUG PRODUCTS, 분석 CRO, CHEMICAL-SYNTHETIC
Compliance: EMA (EU GMP), MHRA (UK GMP), FDA (cGMP), ICH
Controlled Substances: Lowest potential for abuse, High potential for abuse & no medical use, High potential for abuse & medical use, Lower potential for abuse, Narcotic, Low potential for abuse
Region: Europe
Use: Human
Services: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
Markets: PMDA (Japan), FDA (USA), EMA (EU), Health Canada (Canada), MHRA (UK)
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

Batch Size: Small, Medium, Large
Category / Product: 분석 CRO, PARTICLE ENGINEERING, CHEMICAL-SYNTHETIC
Region: Europe
Services: Analytical / QC services, Manufacturing services, Development services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 5,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day)
Compliance: ECOVADIS, ISO, Halal Research Council

Seda Pharma Development Services Ltd
Seda Pharmaceutical Development Services는 통합 의약품 개발 및 임상 약리학을 전문으로 합니다.
Markets: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), 나머지 세계, ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
Batch Size: Small, Medium
Category / Product: FDF / DRUG PRODUCTS
Region: Europe
Use: Human
Compliance: MHRA (UK GMP), ECOVADIS
Services: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 5,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)
Therapeutic Areas of Expertise (ATC): (M) Musculoskeletal system, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (B) Blood and blood forming organs
MAI network supplier
초기 단계 멸균 충진 마감
등록 후 이용 가능 위치
MAI network supplier
비멸균 임상 시설(경구 고형 용량)
등록 후 이용 가능 위치
MAI network supplier
R&D 및 GMP 제조 현장, 영국 더럼 보우번
등록 후 이용 가능 위치
이러한 시설은 기본 기준과 일치하지만 모든 선택적 필터와 일치하지는 않습니다.
Category / Product: SERVICES, FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC
Region: Europe

Category / Product: COSMETICS, 분석 CRO, FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC
Batch Size: Large, Medium
Markets: EMA (EU)
Compliance: ISO, EMA (EU GMP)
Services: Development services, Analytical / QC services, Logistics, Manufacturing services, Quality Assurance services, Regulatory services, Packaging
Use: Human, Veterinary
Therapeutic Areas of Expertise (ATC): (S) Sensory organs, (R) Respiratory system
Region: Europe

Category / Product: COSMETICS, 분석 CRO, FDF / DRUG PRODUCTS
Batch Size: Large, Medium
Markets: EMA (EU), MHRA (UK), EDE (UAE), SFDA (Saudi Arabia)
Compliance: ISO
Services: Development services, Analytical / QC services, Logistics, Manufacturing services, Quality Assurance services, Regulatory services, Packaging
Use: Human
Region: Europe
Batch Size: Large, Medium
Compliance: TITCK (Turkish Health Authorities), ANVISA (Brazil B-GMP), FDA (cGMP), TGA (Australia GMP), Roszdravnadzor (Russia GMP), EMA (EU GMP)
Markets: EMA (EU), Russian Health Authorities, FDA (USA), ANVISA (Brazil), TGA (Australia)
Use: Human, Veterinary
Therapeutic Areas of Expertise (ATC): (S) Sensory organs
Category / Product: 분석 CRO, FDF / DRUG PRODUCTS
Region: Europe

Batch Size: Large, Small, Medium
Compliance: TITCK (Turkish Health Authorities), ANVISA (Brazil B-GMP), COFEPRIS, ISO, ICH, FDA (cGMP), PMDA/MHLW (Japan GMP), Health Canada (Canada GMP), MHRA (UK GMP), ANMAT (Argentina nueva GMP), TGA (Australia GMP), Roszdravnadzor (Russia GMP), ECOVADIS, ISP (Chile BPM), French Service-Public (CIR), World Health Organization (GMP / HACCP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority)
Markets: EMA (EU), MHRA (UK), INVIMA (Colombia), MSPAS (Guatemala), Russian Health Authorities, FDA (USA), PMDA (Japan), Health Canada (Canada), ANMAT (Argentina), 나머지 세계, COFEPRIS (Mexico), EDE (UAE), ISP (Chile), ANVISA (Brazil), DIGEMID (Peru), Turkish Health Authorities, MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia)
Services: Development services, Analytical / QC services, Manufacturing services, Quality Assurance services
Use: Human, Veterinary
Therapeutic Areas of Expertise (ATC): (B) Blood and blood forming organs, (D) Dermatologicals, (N) Nervous system, (J) Antiinfectives for systemic use, (R) Respiratory system, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (H) Systemic hormonal preparations excl. sex hormones and insulins, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism
Region: Europe
Category / Product: BIOLOGICS

53Biologics
53Biologics는 전임상 단계부터 상업적 공급 단계까지 계속해서 발전할 수 있는 엔드투엔드 생물학적 제제 CDMO 도구입니다. 우리는 이것을 위해 만들어졌습니다.
Batch Size: Large, Small, Medium
BSL (Biological Safety Level): 1, 2
Compliance: ISO, FDA (cGMP), World Health Organization (GMP / HACCP), EMA (EU GMP)
Markets: FDA (USA), Health Canada (Canada), ANMAT (Argentina), COFEPRIS (Mexico), ISP (Chile), ANVISA (Brazil), DIGEMID (Peru), MSPAS (Guatemala), INVIMA (Colombia), MHRA (UK), EMA (EU), TGA (Australia)
Services: Development services, Analytical / QC services, Logistics, Manufacturing services, Quality Assurance services, Regulatory services
Use: Human, Veterinary
Region: Europe
Category / Product: BIOLOGICS
Are you a pharmaceutical company seeking a reliable CMO or CDMO partner to accelerate your drug development process? Look no further than MAI CDMO Network. Our advanced search platform connects you with a vast network of qualified contract manufacturers and development organizations worldwide.
Why Choose MAI CDMO Network?
How MAI CDMO Network Works
Key Benefits of Partnering with a CMO/CDMO
Featured Services
Ready to Find Your Ideal CMO/CDMO Partner? Register Now
Explore our platform today and discover how MAI CDMO Network can help you achieve your drug development goals.